Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?
about
Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityA highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectinAnti-obesogenic and antidiabetic effects of plants and mushrooms.Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation.Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions.Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study.Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease.Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.Sorghum extract exerts an anti-diabetic effect by improving insulin sensitivity via PPAR-γ in mice fed a high-fat dietThe toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Adipose targets for obesity drug development.Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines.Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production.A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization.IGFBP-3, hypoxia and TNF-alpha inhibit adiponectin transcriptionCoffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study.Downregulation of ADIPOQ and PPARγ2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis.Adiponectin: a key adipokine in alcoholic fatty liver.Differential transendothelial transport of adiponectin complexes.Leptin as a potential therapeutic target for breast cancer prevention and treatment.Adiponectin and lipoprotein metabolism.A systematic review of Gymnema sylvestre in obesity and diabetes management.Original Research: Polyphenols extracted from grape powder induce lipogenesis and glucose uptake during differentiation of murine preadipocytesObesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis.Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.Adipocytokine levels in obese and non-obese subjects: an observational study.AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice.The Lou/C rat: a model of spontaneous food restriction associated with improved insulin sensitivity and decreased lipid storage in adipose tissue.The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.Probiotics, prebiotics, synbiotics and insulin sensitivity.Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.Long-term dietary nitrite and nitrate deficiency causes the metabolic syndrome, endothelial dysfunction and cardiovascular death in mice.RETRACTED: Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.
P2860
Q28081407-B1A378BF-74F6-4341-962F-35DFAE6F2FDBQ28508158-3A38772B-35AF-4880-80FC-6F2EDF5D7AD6Q30241950-C6CD6497-B2B5-4E4C-A056-48C930101C52Q30353176-319A7873-FD25-4674-B7DC-2DCDE6DCC122Q33604584-C81B93EC-33E4-4146-A2B9-B5FD7408ADBBQ33727352-29A683F9-AA42-4F61-B5BD-B41A4E0A3D32Q33817442-A168FD01-3D17-470F-A160-B3EA5ACA4499Q33825300-7295836B-E87A-4535-8E8D-65F8327F46A7Q35208155-5C3BE49B-42C1-47B4-94B3-E6BFBD50D1EAQ36006122-23FF79A4-B4AE-4FCD-9264-0097397EF9F5Q36124903-22139090-F1A9-4394-83DC-C741E80629B5Q36227469-6EC59DBF-4667-4245-89CD-4FC216DD8AFDQ36328530-22781CFA-84B2-417A-96B8-30780A8F8ED3Q36379383-96906E58-6C8D-4821-8466-52D2F7A65773Q36642651-D91F982C-B527-429E-8F81-22FD536145EAQ36807630-7906A060-38C7-428E-88F4-B15FB127D3A3Q36846138-8B4E1336-2001-427C-9BDF-09CE9EA00585Q36976999-DED434BE-85B2-4247-B536-5A3643C6985FQ36985272-5E91543B-0650-45CF-A88E-87C33A37C9AAQ37238466-C80193A0-C500-497E-830A-099B2655BA49Q37332175-3CA7BA8D-F972-4639-896B-D65CBA16AC4CQ37503883-0BB05899-522E-45CA-B89B-CC06828F2E29Q37505809-C4F44239-4676-4C7D-8BE3-4E4C40864738Q37599498-1A209C13-3C12-46C3-AA37-A5E25F1F7976Q37709376-BCBC7EFD-E099-4A01-8C04-863AFD6D33EFQ38129920-F757FB7C-EECE-47FD-8DA9-EA422C7A3AECQ38156048-D4532911-8900-4CD5-B79B-E2EC4F7904B5Q38865958-C9EE9389-C685-46B6-A56F-F79CA67D7A1FQ39278604-D83F0FCE-4F55-47C2-9809-BF434EBDC5D0Q42518375-CA91B888-8D42-4A2F-A1F3-E4E3A625872AQ43009560-9C80A08B-BB6E-4E9B-A2B2-FCCBF8C711C5Q43294210-D60A255F-C2F9-4A53-8B3C-70741CE16FDBQ44584487-A1035F8D-7BDF-4942-903B-986554A20E78Q46011143-DC90A67C-A959-4DE6-84BA-889F49BBC9D3Q46125862-2A912018-2F2F-4501-AE73-DD9B8FB44286Q46145116-6D4BDD6C-DDED-40E7-81DD-F9423702BD17Q47645890-66980AE7-A14D-453E-9681-460FDF017929Q48457425-C6E4CC4B-24DA-4DF8-B221-1C7F70224BC5Q50205001-0745115B-02DB-44E4-BD43-6E8A92FC781AQ51334529-369CD14B-3452-400B-81CC-B6ECF3C471CF
P2860
Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@ast
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@en
type
label
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@ast
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@en
prefLabel
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@ast
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@en
P2093
P2860
P356
P1476
Adiponectin: a relevant player ...... n hepatic insulin sensitivity?
@en
P2093
Bouskila M
Pajvani UB
Scherer PE
P2860
P2888
P304
P356
10.1038/SJ.IJO.0802908
P407
P478
29 Suppl 1
P577
2005-03-01T00:00:00Z